Effect of numbers of metabolic syndrome components on mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis with metabolic syndrome

被引:2
|
作者
Park, P. G. [1 ]
Pyo, J. Y. [1 ]
Ahn, S. S. [1 ]
Song, J. J. [1 ,2 ]
Park, Y-B [1 ,2 ]
Huh, J. H. [3 ]
Lee, S-W [1 ,2 ]
机构
[1] Yonsei Univ, Dept Internal Med, Div Rheumatol, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Inst Immunol & Immunol Dis, Coll Med, Seoul, South Korea
[3] Hallym Univ, Dept Internal Med, Div Endocrinol & Metab, Sacred Heart Hosp, Anyang, South Korea
关键词
antineutrophil cytoplasmic antibody; vasculitis; metabolic syndrome; components; all-cause mortality; CARDIOVASCULAR RISK; SCORE; DISEASE; ADULTS; INDEX; KOREA;
D O I
10.55563/clinexprheumatol/k4m3it
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective This study investigated the effect of the number of metabolic syndrome (MetS) components on all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV) with MetS. Methods The medical records of 93 AAV patients with MetS were retrospectively reviewed. MetS was diagnosed when three or more the following MetS components for Asians were met: (i) increased waist circumference; ii) high blood pressure; (iii) hypertriglyceridaemia; (iv) low level of high-density lipoprotein (HDL)-cholesterol; and (v) impaired fasting glucose (IFG) or type 2 diabetes mellitus (T2DM). All-cause mortality was defined as death owing to any aetiology. Results The median age was 61.4 years and 33 patients were men. Among 93 AAV patients with MetS, as the number of MetS components increased, the cumulative patient survival rate significantly decreased (p = 0.024). Compared to surviving AAV patients with MetS, deceased AAV patients with MetS were older, had higher Birmingham vasculitis activity score (BVAS) and Five-factor score (FFS), a lower frequency of IFG or T2DM, and a higher number of MetS components. In the multivariable Cox analysis, AAV patients with MetS who had all five MetS components were approximately 62 times more susceptible to all-cause mortality than those who had only three components. In terms of IFG or T2DM, patients with only IFG exhibited a significantly lower cumulative patients??? survival rate than those without. Conclusion The presence of many MetS components at the initial diagnosis of AAV was an independent and significant predictor of all-cause mortality in AAV patients with MetS.
引用
收藏
页码:758 / 764
页数:7
相关论文
共 50 条
  • [41] Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis
    Moran, Sarah
    Little, Mark A.
    CURRENT OPINION IN RHEUMATOLOGY, 2014, 26 (01) : 37 - 41
  • [42] Treatment of antineutrophil cytoplasmic antibody-associated vasculitis: update
    Cruz Santana, Alfredo Nicodemos
    Woronik, Viktoria
    Radu Halpern, Ari Stiel
    Barbas, Carmen S. V.
    JORNAL BRASILEIRO DE PNEUMOLOGIA, 2011, 37 (06) : 809 - 816
  • [43] ECULIZUMAB FOR REFRACTORY ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS
    Villagrasa, Tania
    Uriol, Miguel
    Obrador, Aina
    Allende, Natalia
    Egea, Cristina
    Montaner, Mercedes
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 431 - 431
  • [44] ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS IN A XENOGENEIC MODEL
    WALKER, BAM
    SMITH, T
    KIM, SSW
    JOHNSTON, G
    FASEB JOURNAL, 1994, 8 (04): : A320 - A320
  • [45] Treatment of antineutrophil cytoplasmic antibody-associated vasculitis with rituximab
    Cartin-Ceba, Rodrigo
    Fervenza, Fernando C.
    Specks, Ulrich
    CURRENT OPINION IN RHEUMATOLOGY, 2012, 24 (01) : 15 - 23
  • [46] Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis
    Mukhtyar, C.
    Hellmich, B.
    Jayne, D.
    Flossmann, O.
    Luqmani, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (06) : S93 - S99
  • [47] SEVERE INFECTION IN ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS
    Mesbahi, Tasnim
    Barbouch, Samia
    Sallami, Nada
    Najjar, Mariem
    Kaaroud, Hayet
    Hedri, Hafedh
    Goucha, Rim
    Ben Hamida, Fathi
    Ounissi, Mondher
    Ben Abdallah, Taieb
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [48] Predictor of depressive disorders in patients with antineutrophil cytoplasmic antibody-associated vasculitis
    Jan-Di Yun
    Junghee Ha
    Solah Kim
    Hyung Ah Park
    Juyoung Yoo
    Sung Soo Ahn
    Seung Min Jung
    Jason Jungsik Song
    Yong-Beom Park
    Sang-Won Lee
    Clinical Rheumatology, 2019, 38 : 3485 - 3491
  • [49] Azathioprine Intolerance in Japanese Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis
    Morishita, Michiko
    Watanabe, Haruki
    Yan, Minglu
    Zeggar, Sonia
    Hiramatsu, Sumie
    Ohashi, Keiji
    Miyawaki, Yoshia
    Katsuyama, Eri
    Katsuyama, Takayuki
    Narazaki, Mariko Takano
    Tatebe, Noriko Toyota
    Watanabe, Katsue Sunahori
    Kawabata, Tomoko
    Sada, Ken-Ei
    Wada, Jun
    INTERNAL MEDICINE, 2017, 56 (13) : 1645 - 1650
  • [50] Clinical analysis of patients with myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis
    Shuai, Z. W.
    Lv, Y. F.
    Zhang, M. M.
    Hu, Z. Y.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (02): : 5296 - 5303